Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review-Reference-Cited by-同舟云学术

Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review

Published:2024-07 Issue: Volume:73 Page:102660
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Singh Manasvi,Kumar Ashish,Khanna Narendra N.,Laird John R.,Nicolaides Andrew,Faa Gavino,Johri Amer M.,Mantella Laura E.,Fernandes Jose Fernandes E.,Teji Jagjit S.,Singh Narpinder,Fouda Mostafa M.^ORCID,Singh Rajesh,Sharma Aditya,Kitas George,Rathore Vijay,Singh Inder M.,Tadepalli Kalyan,Al-Maini Mustafa,Isenovic Esma R.,Chaturvedi Seemant,Garg Deepak,Paraskevas Kosmas I.,Mikhailidis Dimitri P.,Viswanathan Vijay,Kalra Manudeep K.,Ruzsa Zoltan,Saba Luca,Laine Andrew F.,Bhatt Deepak L.,Suri Jasjit S.^ORCID

Publisher

Elsevier BV

Reference120 articles.

1. Biomarker development in the precision medicine era: lung cancer as a case study;Vargas;Nat Rev Cancer,2016

2. Precision medicine in the era of artificial intelligence: implications in chronic disease management;Subramanian;J Transl Med,2020

3. Personalised medicine in psychiatry: problems and promises;Ozomaro;BMC Med,2013

4. Personalised medicine: part 1: evolution and development into theranostics;Vogenberg;P T,2010

5. The role of ai in drug discovery: challenges, opportunities, and strategies;Blanco-Gonzalez;Pharmaceuticals,2023

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence in Cardiovascular Diseases and Vascular Surgery;Angiology;2024-08-10

2. The Genetic Blueprint of Cardiovascular Therapy: Pharmacogenomics for Improved Efficacy and Safety;Journal of Indian College of Cardiology;2024-07

3. Innovative E-Health Technologies for Cardiovascular Disease Treatment: A 2024 Updated Systematic Review and Meta-Analysis;2024-06-30